ABSTRACT Sixty crossbred barrows were used to study the effect of ractopamine ( a phenethanolaminel @-adrenergic agonist) treatment and its withdrawal on muscle growth and on the relative abundance of skeletal muscle a-actin (sk-a-actin) mRNA and of liver and longissimus muscle IGF-I mRNA at 4 wk. Ractopamine was fed (20 ppm) for periods of 2, 4, and 6 wk (six pigs per group). Additional pigs (four per group) were fed ractopamine (20 ppm) for 6 wk and then slaughtered 1, 3, and 7 d after withdrawal of ractopamine. Ractopamine increased ( P < .05) longissimus muscle weight and protein content, although protein concentrations were not different. The increased muscle weight and protein content attained by feeding ractopamine for 6 wk was retained when ractopamine was withdrawn. The RNA and DNA concentrations did not change, whereas total DNA and RNA content per muscle was 18 and 26.7% greater, respectively, in ractopamine-treated pigs at 4 wk, but there were no differences at 2 or 6 wk or among the withdrawal groups. The relative abundance of sk-aactin mRNA in the longissimus muscle was 41 and 62% greater ( P < .05) in treated animals at 2 and 4 wk but was similar to that in controls at 6 wk and during the withdrawal period. The relative abundance of IGF-I mRNA in liver and longissimus muscle was not altered with ractopamine treatment for 4 wk. These results indicate that the ractopamine-enhanced muscle growth may result from increased myofibrillar gene expression at the pretranslational level, which is maximal with short-term treatment of ractopamine. It also seems that ractopamine does not pretranslationally regulate IGF-I synthesis when ractopamine maximally induces sk-a-actin mRNA abundance.
Introduction
Administration of the phenethanolamine ractopamine t o finishing pigs increases muscle mass, total muscle protein and RNA content, and fractional protein synthesis rates (Bergen et al., 1989) . This is due in part to enhanced fractional synthesis rates of skeletal muscle a-actin ( sk-a-actin) and increased relative abundance of sk-a-actin mRNA . A time-course study in which muscle growth and abundance of sk-a-actin is monitored J. Anim. Sci. 1993. 71:3319-3326 during administration and withdrawal of ractopamine to pigs is necessary to identify possible biological mechanisms that mediate ractopamine-induced muscle hypertrophy. The major objective of the present study was t o monitor changes in skeletal muscle protein metabolism and sk-a-actin mRNA abundance in pigs fed ractopamine during a 6-wk feeding period and a subsequent 7-d withdrawal period. Because IGF-I increases protein synthesis in cultured muscle cells (Ewton and Florini, 1980; Gulve and Dice, 1989; Roe et al., 1989) and increases skeletal muscle protein synthesis when administered to dwarf mice (Pel1 and Bates, 19891 , IGF-I may mediate some of the hypertrophic action of ractopamine on skeletal muscle. Therefore, a second objective of this study was to determine whether ractopamine increases the relative abundance of IGF-I mRNA in liver and skeletal muscle of pigs at 4 wk when ractopamine was found to maximally induce sk-a-actin mRNA.
Materials and Methods
Animals, Treatments, and Sample Collection. Sixty crossbred barrows (Yorkshire x Hampshire x Duroc) with an average initial BW of 72.5 kg were randomly divided into two groups, one group of 36 pigs for a ractopamine feeding time course experiment and another group of 24 pigs for a ractopamine withdrawal experiment. All pigs were housed at the Swine Research Facility at Michigan State University and given ad libitum access to a 16.6% CP corn-soybean meal finishing diet (Table 1 ) . The first group (36 pigs) was allotted to four pens (nine pigs/pen) and pigs in two of the pens were fed the phenethanolamine ractopamine (1-[4-hydroxyphenyl1-2-[ 1 methyl-3(4 hydroxyphenyl) propylamino] ethanol, Eli Lilly, Indianapolis, IN). Pigs were fed the control diet or the control diet plus 20 ppm of ractopamine for 2, 4, or 6 wk (three pigs per pen per feeding period). Pigs were slaughtered at the Michigan State University Meat Laboratory immediately after the designated feeding period, and tissues were collected and carcass measurements were obtained. The 24 pigs for the ractopamine withdrawal experiment were assigned t o four pens (six pigs/pen) and fed the control diet with or without 20 ppm of ractopamine (two pens/treatment) for 6 wk. Ractopamine was then withheld and the pigs were fed the control diet for an additional 1, 3, or 7 d (two pigs per pen per withdrawal time) before slaughter and subsequent collection of tissue samples and carcass measurements.
Immediately after stunning and exsanguination, samples of the left longissimus muscle and the liver were excised and weighed. The muscle sample was dissected free of visible fat and connective tissue, and both tissues were cut into cubes of approximately 8 cm3 and frozen by submersion in liquid nitrogen. All samples were collected and frozen within 5 min of stunning and then stored at -80°C for subsequent analysis. The remaining longissimus muscle of the left side was removed, dissected free of fat, weighed, and added to the above sample weight to obtain total left longissimus muscle mass. A portion of the frozen Zn, 74.8 mg; Fe, 9.4 mg;Mn, 37.4 mg; Cu, 9.9 mg; I, .5 mg;Se, 1 mg.
longissimus sample was powdered with solid C02 at -70°C and used to determine protein, RNA, and DNA contents. Nucleic acids (DNA and RNA) were assayed according t o a modified procedure (Munro and Fleck, 1969) as described by Bates et al. (1985) and protein was determined by the micro-Kjeldahl method (AOAC, 1980) .
Determination of Skeletal a-Actin m R N A Abundance. Total RNA for quantification of sk-a-actin mRNA was isolated from longissimus muscle of each pig by a combination of urea-LiC1 precipitation (Minty et al., 1981) and guanidine isothiocyanate-CsC1 centrifugation (Chirgwin et al., 1979) as previously described Skjaerlund et al., 1993) . The RNA samples were scanned from A220 t o A320 and run on agarose gels with ethidium bromide staining to check for 18,283 RNA bands to evaluate integrity. Northern blot analysis (not shown) was also performed to ensure specificity of hybridization as previously reported by Skjaerlund et al. (1993) . Relative abundance of sk-a-actin mRNA was determined by dot-blot hybridization methods as previously described ) using a minifold apparatus (Schleicher and Schuell, Keene, NH) with 96 wells. Total RNA was blotted onto nylon membrane (Zetabind@) at .l, .2, .3, .4 pg of longissimus muscle from each pig RNA per dot. The conditions for prehybridization (50% formamide, 5x sodium chloride-sodium citrate (SSC), lox Denhardts, 50 mM sodium phosphate, 1 mM EDTA, 500 pg/mL yeast tRNA, 42"C), hybridization (55% formamide, 5x SSC, 1 . 2~ Denhardts, 50 mM sodium phosphate, 1 mM EDTA, 500 pg/mL yeast tRNA, 2 x106 cpm of 32P-labeled probe/mL, 42°C ) and subsequent washings ( . l x SSC, . l % SDS, 65°C) were similar to those described by Skjaerlund et al. (1993) . The cDNA probe, a full-length probe coding for human sk-a-actin obtained from L. Kedes' laboratory (University of Southern California, School of Medicine, Los Angeles, CA) and characterized by Gunning et al. (19831, was labeled with [32P] deoxycytidine triphosphate (3,000 Ci/mmol, Amersham, Arlington Heights, IL). The insert was excised from the plasmid (pHMaA-1) by digestion with PuuII and PstI before labeling. It was previously determined that this probe can be used with livestock species (Skjaerlund et al., 1993) . Dried blots were exposed to x-ray film (Kodak, Rochester, NY) in cassettes containing two intensifying screens (Dupont, Wilmington, DE) and the extent of hybridization was quantified by densitometry. For comparison purposes, all procedures were conducted simultaneously; all were prehybridized, hybirdized, and washed in the same solution and exposed together to the same x-ray film.
Determination of IGF-I m R N A Abundance. The RNA for quantification of IGF-I mRNA was isolated from longissimus muscle and liver by an acid guanidine thiocyanate phenol chloroform procedure (Chomczynski and Sacchi, 1987) . Relative abundance of IGF-I mRNA in liver and skeletal muscle RNA was quantified using a solution hybridization-nuclease protection assay, which is approximately 20 to 50 times more sensitive than membrane blotting. This protocol was patterned after that of Krieg and Melton (1987) as described in detail by Grant et al. (1991) . A 580-bp porcine IGF-I cDNA (Tavakkol et al., 1988) subcloned into the EcoRI site of the multiple cloning site of pGEM-1 (Promega, Madison, WI) was obtained from F. Simmen (University of Florida, Gainesville). The cDNA encodes a 25-amino acid leader peptide, the mature (processed) 70-amino acid porcine IGF-IA peptide, and a 35-amino acid carboxyterminal extension peptide. The recombinant plasmid containing the IGF-I cDNA was linearized with PvuII and then used as a template in an SP6 Transcription Kit (Boehringer Mannheim Biochemicals, Indianapolis, I N ) with [32Pldeoxyuridine triphosphate (400 Ci/ mmol, Amersham) for the synthesis of a [32PlUTP-labeled RNA probe. The probe was purified by 1.2% agarose gel electrophoresis and electroelution (Maniatis et al., 1982) and then used in a solution hybridization assay with subsequent electrophoresis as described by Grant et al. (1991) . Protected fragments 580 bp in length were excised from the sample lanes of the gels and radioactivity was quantified by liquid scintillation analysis. Results were corrected for background by subtracting the values obtained from the tRNA negative controls and normalized with the aid of an internal control standard, RNA isolated from liver of a somatotrophintreated pig.
The relative abundance of P-tubulin mRNA was also determined on the 4-wk liver and muscle RNA samples by Northern blot analysis as a constitutive marker. Northern blot analysis was conducted as described by Grant et al. (1991) . A mouse P-tubulin cDNA (Sullivan and Cleveland, 1986 ) obtained from D. Cleveland (The Johns Hopkins University, Baltimore, MD) was used as a probe for hybridization. Aliquots (12 pg) of longissimus muscle RNA and aliquots (20 pg) of liver RNA were separated electrophoretically, transferred to nitrocellulose (Schleicher and Schuell, Keene, NH) , and hybridized, and the blots were washed (. l x SSC, .l% SDS, 55°C). Blots were later stained with methylene blue as described by Maniatis et al. (1982) to visualize the 18s and 28s ribosomal bands to confirm that equivalent amounts of RNA were loaded onto gels and that the transfer efficiency was similar among lanes.
Statistical Analysis. All data were statistically analyzed using the GLM procedure of SAS (1987) . A split-plot design was used. The effect of ractopamine was tested using variation among pens (i.e., pen [treatment] ) as the error term. The effects of feeding or withdrawal times and the interaction of treatment with time were tested using pen (treatment x time) as the error term. Because of the low number of pens per treatment and degrees of freedom for the error terms, variation among pens was pooled with variation among pigs and used as the error term in cases in which the F-statistic for variation for pens was < 2F.50 as outlined by Gill (1989) ; however, there is potential for bias from pooling the sum of squares (and corresponding degrees of freedom) for pens and animals. Means comparisons were made using the Student-Newman-Keuls procedures in SAS ( 1987). Skeletal-a-actin mRNA abundance data were analyzed within each feeding or withdrawal time using the Student's t-test (Gill, 1978) .
Results and Discussion
Feeding 20 ppm of ractopamine to pigs in a finishing diet increased ( P < .05) longissimus muscle weight by 17.3% at 2 wk, 19% at 4 wk, and 13.8% at 6 wk relative to control longissimus muscle weights (Table 2 ). Protein contents of the longissimus muscle from treated pigs were 18, 19, and 17% greater than those of muscle from control pigs a t 2, 4, and 6 wk, respectively. Protein concentrations were not affected by treatment. In a similar study, Bergen et al. ( 1989) found that ractopamine increased semitendinosus muscle mass by 25% over controls at 4 wk but only by 9% at 6 wk. Other P-adrenergic agonists have provided similar responses. In young male rats, clenbuterol increased weights of selected muscles by 18 to 39% over controls after 11 d of feeding, but only by 0 to 6% after 25 d (Reeds et al., 1986) . Cimaterol has also been demonstrated to increase muscle weight by 27 t o 33% after 7 wk of treatment, but the difference between controls and cimaterol-fed lambs was less after 12 wk (Beermann et al., 1987) . Kim et al. (1992) found increased weight gain in skeletal muscles of rats fed cimaterol for up to 2 wk, but no further increase occurred with feeding cimaterol for an additional 2 wk. Rats fed cimaterol had the greatest acceleration in gain within 1 wk and rats no longer gained at an accelerated rate after 1 wk (Eadara et al., 1989) . Likewise in their study, fractional accretion rates increased up to 120% in response t o cimaterol at 1 wk, but no changes in fractional accretion rates were detected thereafter. It seems that &adrenergic agonists enhance muscle mass early on and that prolonged feeding of them does not continue t o increase muscle weight, but the early increment of gain is maintained. Withdrawal of ractopamine for up to 7 d after feeding it for 6 wk did not diminish the increased longissimus muscle weight or protein content gained during the treatment period (Table 3) . This further suggests that the effect of P-adrenergic agonists on skeletal muscle accretion occurs early on and that the net increase is maintained for at least 7 d after withdrawal of the agonist. The ractopamineinduced gain also has been shown to be maintained in steers even after a 78-d withdrawal period (Schiavetta et al., 1990) .
ET AL.
Content of RNA was increased by 26.7% compared with the controls at 4 wk ( Table 2 ). There were no differences between treatment groups in muscle RNA content at 2 or 6 wk or between the withdrawal groups ( Table 3) . There were no significant differences in muscle RNA concentrations, although RNA concentrations tended to be greater in pigs fed ractopamine for 4 wk and lower in pigs fed ractopamine for 6 wk, including those after withdrawal of ractopamine. These results are similar to those reported by Bergen et al. (1989) in which ractopamine-fed pigs had increased RNA content by 36% at 4 wk but not at 2 or 6 wk. Concentrations of RNA also showed the same trend but were not statistically different. Feeding cimaterol also increased RNA concentrations initially in rat skeletal muscle (Kim et al., 1988) . Content of RNA in rat hindlimb muscle increased greatly after 1 wk of cimaterol feeding, but the increase was less pronounced after 2 and 4 wk (Eadara et al., 1989) . Feeding cimaterol to lambs for 7 and 12 wk increased RNA content by 36 and 37%, respectively, although RNA concentrations were not altered (Beermann et al., 1987) . The differences in RNA content between controls and clenbuterol-fed rats were greatest at 11 d, paralleling the differences in muscle mass (Reeds et al., 1986) .
Longissimus muscle DNA concentration was not altered by ractopamine at any sampling period. Feeding ractopamine for 4 wk increased muscle DNA content by 18% above that of control pigs, but muscle DNA content did not differ significantly between treatment groups at other sampling times. Because of the trends in nucleic acid and protein contents, ratios of protein:DNA, protein:RNA, and RNA:DNA were not changed by feeding ractopamine. Even though ractopamine increased the proliferation of cultured chick breast muscle satellite cells , the recruitment of additional satellite cell nuclei does not seem to be a prerequisite for accelerated accretion of skeletal muscle, because DNA concentrations are not enhanced with the feeding of ractopamine. The increased protein accretion and RNA account for the majority of the ractopamine-induced muscle hypertrophy. The fact that DNA concentration remained relatively constant over the treatment period implies that DNA increases proportionally with the ractopamine-induced muscle hypertrophy. In rats fed cimaterol, DNA content did not differ at 1 wk but increased after 2 and 4 wk after the early induced hypertrophy evident at 1 wk (Eadara et al., 1989) . Longissimus muscle weight, protein content, and RNA content in pigs fed ractopamine for 2 and 4 wk were similar to those in control pigs at 4 and 6 wk, respectively; thus, ractopamine is similar to cimaterol in that it accelerates muscle growth to attain more mature stages sooner, as suggested by Beermann et al. (1987) .
To quantify differences in the relative abundance of sk-a-actin mRNA, longissimus RNA (. 1, .2, .3, and .4 pg RNNdot) from each pig was hybridized to the sk-aactin probe using dot-blot hybridization. The results, quantified by densitometry, are shown in Figure 1 . Northern blot analysis (not shown) revealed that hybridization of the sk-a-actin RNA probe was observed as a single band, approximately 1.6 kb in size, as previously reported by Skjaerlund et al. (1993) . At 2 and 4 wk, pigs fed ractopamine had 41 and 6296, respectively, greater ( P < .05) sk-a-actin mRNA abundance than control pigs. Helferich et al. (1988 Helferich et al. ( , 1990 demonstrated a twofold increase in sk-a-actin mRNA abundance in pigs fed ractopamine for 4 wk and Koohmaraie et al. (1991) showed a 30% increase in sk-a-actin mRNA abundance in lambs fed the 0-adrenergic agonist L644,969 for 6 wk. Ractopamine also increased myosin light chain mRNA abundance in longissimus muscle from steers (Smith et al., 1989) . The increase in sk-a-actin mRNA abundance is consistent with ractopamine-enhanced fractional synthesis rates of a-actin observed in pigs (Bergen et al., 1989; Helferich et al., 1990) and with the increased fractional accretion rates in hindlimb muscle after feeding cimaterol to rats (Eadara et al., 1989) . The increased muscle mass observed with feeding 0-adrenergic agonists seems to be due in part to pretranslational enhancement of myofibrillar protein synthesis. The increased abundance of sk-a-actin mRNA could result from several pretranslational events (i.e., increased transcription, enhanced processing of the pre-mRNA, or greater stability of the mature message).
Beta-adrenergic agonists most likely elevate mRNA abundance of muscle proteins sooner than 2 wk. In rats fed cimaterol, RNA concentration in skeletal muscle increased after 3 d of administration, and the effect was lost at approximately 2 wk of treatment (Kim et al., 1988) . In our study, the relative abundance of sk-a-actin mRNA was not significantly
Ractopamine Treatment (wk)
Ractopamine Withdrawal (d) Figure 1 . Abundance of skeletal-a-actin [sk-a-actin) mRNA in longissimus muscle of ractopamine-treated pigs relative to controls. The abundance of sk-a-actin mRNA was quantified using dot-blot hybridization. The RNA [.l, .2, .3, .4 pg/dot for each sample] isolated from longissimus muscle of each animal was blotted onto nylon membrane. All samples were hybridized at one time to the human sk-a-actin cDNA probe and washed at 65°C with .lx SSC and . l % SDS. The blots were subjected to autoradiography at -80' C simultaneously. Extent of hybridization was quantified by densitometry. Abundance of sk-a-actin mRNA in ractopamine-treated pigs is expressed relative to the respective controls. An asterisk indicates P < .05. different between pigs fed ractopamine for 6 wk and control pigs, and no differences were detected after 1, 3, or 7 d of ractopamine withdrawal (Figure 1 ). Content of RNA or concentration also did not differ after feeding ractopamine for 6 wk, which corroborates data reported by Bergen et al. (1989) . The increase in muscle mass and relative abundance of sk-a-actin mRNA resulting from feeding ractopamine may occur before 6 wk. However, the additional muscle mass attained a t 6 wk is maintained after withdrawal of ractopamine for at least 7 d. Stimulation of muscle accretion by feeding ractopamine seems to wane with chronic administration. This attenuation effect with prolonged treatment may be due in part to a change in 0-adrenoreceptor density. Kim et al. (1992) and Rothwell et al. ( 1987) reported a reduction of up to 50% in the number of skeletal muscle 0-receptor binding sites that preceded the attenuation of muscle gain, and receptor affinity was not altered at any time point. Intermittent feeding, rather than continuous feeding, of 0-adrenergic agonists may prevent the attenuation in muscle gain that occurs over time, as suggested by McElligott et al. (1989) .
It is not known whether the effects of ractopamine on muscle growth are mediated by IGF-I, which does increase skeletal muscle protein synthesis during muscle hypertrophy. Although liver was at one time considered the principal site of IGF-I synthesis (Salmon and Daughaday, 19571 , myoblasts and myotubes also synthesize IGF-I (Hill et al., 1984; Tollefsen et al., 1989) . We examined the effect of ractopamine on the relative abundance of liver and skeletal muscle IGF-I mRNA only at 4 wk, because the effects of ractopamine on protein, RNA and DNA content, and sk-a-actin mRNA relative abundance were greatest at this sampling time. Autoradiograms from the IGF-I solution hybridization assays are shown in Figure 2 . To quantify relative abundance of IGF-I mRNA, the 580-bp protected fragments were excised from the gels and subjected to liquid scintillation analysis. Ractopamine had no effect ( P > .2) on IGF-I mRNA abundance in either liver or longissimus muscle (Figure 3 ) . These observations, particularly in liver, are consistent with the serum growth hormone concentrations obtained a t slaughter, between 0700 and 0800 from ractopamine-fed and control pigs (1.65 f .82 and 1.57 f .77 ng/mL serum, respectively). Likewise, growth hormone concentrations in extracts of the anterior pituitary did not differ (952 f 237 and 944 f 265 pgI100 mg of pituitary tissue for ractopa-E mine-fed and control T r pigs, respectively). Figure 2 . Autoradiograms of IGF-I mRNA abundance in liver and longissimus muscle from six ractopaminefed (R) and six control (C) pigs. Liver and muscle RNA was isolated and analyzed via a solution hybridizationnuclease protection assay using a porcine IGF-I cDNA as a template to synthesize an antisense 32P-labeled RNA probe. After hybridization to 100 pg of RNA at 65'C for 14 h, 133 units of nuclease S 1 was added and incubation continued for 1 h at 37°C. Protected RNA fragments were RNA fragments that were electrophoretically separated in 5% acrylamideI8 M urea gels and then subjected to autoradiography. Each lane represents one pig from the 4-wk treatment groups.
IGF-I
1GF-I @-tubulin 0-tubulin Figure 3 . Abundance of IGF-I mRNA and P-tubulin in liver and longissimus muscle from ractopamine-treated pigs relative to controls. Protected fragments 580 bp in length from the solution-hybridization-nuclease protection assay were excised from the 5% acrylamideI8 M urea gels and radioactivity quantified by liquid scintillation analysis. Results were corrected for background by subtracting the values obtained from the tRNA negative controls and normalized with the aid of an internal control standard (RNA isolated from liver of a somatotropin-treated pig]. /3-tubulin mRNA abundance was quantified by densitometry of autoradiographs from Northern blotting. Abundance of IGF-I and 0-tubulin mRNA in ractopamine-treated animals is expressed relative (percentage) to the 4-wk control pigs.
There were no differences ( P > .05) between controls and ractopamine-treated animals.
Lack of a n effect of ractopamine on liver IGF-I mRNA abundance is consistent with the following observations. First, increased abundance of liver IGF-I mRNA would likely result in greater liver IGF-I synthesis, and, presumably, greater circulating concentrations of IGF-I. Beermann et al. (1987) were unable to detect any change in plasma IGF-I concentrations in sheep fed the &adrenergic agonist cimaterol. Second, if circulating concentrations of IGF-I were elevated, then serum from treated animals would be expected to exhibit greater anabolic activity when included in muscle cell cultures, because IGF-I increases proliferation and protein synthesis of muscle cells in culture (Ewton and Florini, 1980; Gulve and Dice, 1989; Roe et al., 1989) . McElligott and Chaung (1987) demonstrated that serum from rats treated with clenbuterol and serum from normal rats had similar effects on protein synthesis and degradation and cell proliferation in cultures of L8 myoblasts. Given these data, hepatic or circulating IGF-I does not seem to play a major role in mediating P-adrenergic agonist-induced muscle hypertrophy.
A direct action of ractopamine on muscle protein metabolism may, however, be mediated by local synthesis of IGF-I in skeletal muscle. Ractopamine and myofibrillar protein synthesis in cultured rat myotubes. J.
has been demonstrated to increase Drotein svnthesis directly in cultures of L6 myotubes (Adeola et al., 1989; Anderson et al., 19901 , suggesting that 0-adrenergic agonists may act directly on skeletal muscle in vivo to increase muscle growth, obviating the need for circulating IGF-I. Ractopamine may trigger local synthesis of IGF-I that could then act on muscle to increase protein synthesis. Even though no differences in the relative abundance of IGF-I mRNA were detected in muscle at 4 wk when ractopamineinduced muscle hypertrophy and sk-a-actin mRNA abundance were greatest, it is possible that changes in skeletal muscle IGF-I mRNA abundance may have occurred earlier. Attenuation may have already occurred by 4 wk, perhaps due to a decrease in 6-adrenoreceptor density. Kim et al. (1992) demonstrated that the decrease in receptor number precedes attenuation of muscle gain. Quantification of tissue and serum IGF-I peptide concentrations would provide additional information; however, such measurements do not distinguish between endocrine and paracrine and(or 1 autocrine roles of IGF-I because the presence of muscle IGF-I peptide may be the result of local synthesis or contribution from other tissues associated with skeletal muscle. Changes in IGF-I receptor number and affinity in skeletal muscle and alterations in the distribution of IGF-binding proteins among tissues of pigs fed ractopamine have not been examined and may also represent mechanisms of growth regulation. These changes could occur without changes in IGF-I mRNA or peptide concentrations. Alternatively, it is possible that IGF-I does not play a role in mediating ractopamine-induced muscle hypertrophy in pigs. The actions of ractopamine may be mediated by other growth factors or may involve a number of different signal transduction mechanisms.
Implications
The results of this study indicate that ractopamineenhanced muscle growth is part,ly due to increased gene transcription or other pretranslational events that increase mRNA abundance of a-actin and probably other myofibrillar proteins as well. Continuous feeding of ractopamine may have a greater short-term effect rather than a sustained, long-term effect on aactin gene expression. Ractopamine does not seem to regulate IGF-I synthesis pretranslationally a t 4 wk, the time of maximum treatment response.
